An in-office evaluation of four dietary supplements on natural killer cell activity

Townsend Letter for Doctors and Patients, Feb-March, 2005 by James Belanger

References

1. http://seer.cancer.gov/cgi-bin/csr/1975_2001/search.pl

2. Wu J. et al. 2003. Natural Killer Cells and Cancer. Adv Cancer Res. 90:127-56

3. Tratkiewicz JA, Szer J. 1990. Loss of natural killer activity as an indicator of relapse in acute leukaemia. Clin Exp Immunol. May;80(2):241-6.

4. Sorskaar D, Lie SO, Forre O. 1985. Natural killer cell activity of peripheral blood and bone marrow mononuclear cells from patients with childhood acute lymphoblastic leukemia. Acta Paediatr Scand. May;74(3):433-7.

5. Sorskaar D, Forre O, Stavem P. 1988. Natural killer cells in chronic leukemia. Function and markers. Int Arch Allergy Appl Immunol. 87(2):159-64.

6. Schantz SP, et al. 1987. Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer. Cancer Immunol Immunother. 25(2):141-8.

7. Schantz SP, Campbell BH, Guillamondegui OM. 1986. Pharyngeal carcinoma and natural killer cell activity. Am J Surg. Oct; 152(4):467-74.

8. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. 2000. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. Jun 21;92(12):994-1000.

9. Garzetti GG et al. 1995. Natural killer cell activity in patients with invasive cervical carcinoma: importance of a longitudinal evaluation in follow-up. Gynecol Obstet Invest. 40(2):133-8.

10. Taketomi A et al. 1998. Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Cancer. 1998 Jul 1;83(1):58-63.

11. Ortac R, Aktas S, Diniz G, Erbay A, Vergin C. 2002. Prognostic role of natural killer cells in pediatric mixed cellularity and nodular sclerosing Hodgkin's disease. Anal Quant Cytol Histol. Oct;24(5):249-53.

12. Tajima F. et al. 1996. Natural Killer Cell Activity and Cytokine Production as Prognostic Factors in Adult Acute Leukemia. Leukemia. Mar;10(3):478-82

13. Ogata H. et al. 1989. A clinical study of a multiregression analysis on the NK activity and related clinical factors in patients with lung cancer. Gan No Rinsho. 1989 Apr;35(5):554-9.

14. Fujisawa T, Yamaguchi Y. 1997. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung. Cancer. Feb 1;79(3):474-81.

15. Cosiski Marana HR, Santana da Silva J, Moreira de Andrade J. 2000. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer. Gynecol Oncol. Sep;78(3 Pt 1):318-23.

16. Aparicio-Pages MN, Verspaget HW, Pena AS, Lamers CB. 1991. Natural killer cell activity in patients with adenocarcinoma in the upper gastrointestinal tract. J Clin Lab Immunol. May;35(1):27-32.

17. Yang YB. 1990. Detection of natural killer cells activity in patients with laryngeal carcinoma using the 51Cr release assay. Zhonghua Er Bi Yan Hou Ke Za Zhi. 1990;25(1):42-4, 63.

18. Apostolopoulos A, Symeonidis A, Zoumbos N. 1990. Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia. Eur J Haematol. Jan;44(1):39-44.